Crucially (re combo study we're all waiting on):
Functional analysis results are due imminently with the cellular analysis to follow next month. Any applicable patent filings would bemade ahead of disclosure of the results.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 999 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 1000 | 1 |
View Market Depth
| Last trade - 09.05am 18/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable